Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001 Read more
Trodelvy (sacituzumab govitecan) Granted European Commission Marketing Authorization for Treatment of Metastatic Triple-Negative Breast Cancer in Second Line Read more
FDA Approves First Treatment for Common Type of Post-Transplant Infection that is Resistant to Other Drugs Read more
Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001 Read more
Nykode Therapeutics (Formerly Vaccibody) Enters Into Multi-target License and Collaboration Agreement With Regeneron Read more
BioNTech Receives FDA Fast Track Designation for its FixVac Candidate BNT111 in Advanced Melanoma Read more